Trademark Overview
On Friday, September 13, 2024, a trademark application was filed for CRYPTOMAP with the United States Patent and Trademark Office. The USPTO has given the CRYPTOMAP trademark a serial number of 98748841. The federal status of this trademark filing is RESPONSE AFTER NON-FINAL ACTION - ENTERED as of Wednesday, April 2, 2025. This trademark is owned by Epitopea Inc.. The CRYPTOMAP trademark is filed in the Chemical Products, Pharmaceutical Products, Computer & Software Services & Scientific Services, and Medical & Beauty Services & Agricultural Services categories with the following description:
Pharmaceutical products and preparations for the treatment of cancer; pharmaceutical products and preparations for the prevention of cancer; vaccines; tumor antigens for medical use; pharmaceutical preparations for the prevention and treatment of immune system related diseases and disorders; pharmaceutical preparations for regulating the immune system; immunoassay reagents for medical use; proteins with diagnostic and therapeutic uses, namely, protein arrays for medical diagnosis purposes; diagnostic reagents for medical use; diagnostic and testing preparations for clinical, medical and medical laboratory use, namely, diagnostic kits consisting primarily of monoclonal antibodies, buffers, and reagents for use in oncology and immunology testing for medical purposes; diagnostic test kits for medical purposes, namely, diagnostic kits comprising diagnostic agents, preparations and substances for medical use; antibodies for medical purposes
Active chemical ingredients for use in the manufacture of anti-cancer therapeutics and vaccines; chemicals, reagents and substances, being diagnostic reagents, buffers, nucleic acids, peptides, antibodies and immunological peptides for medical research; antibodies for scientific purposes; immunoassay reagents, other than for medical or veterinary use; diagnostic preparations and reagents for scientific or research use; test kits for scientific or research use, namely, nucleic acids, peptides, antibodies, buffers and reagents; proteins, namely, antigens, antibodies, and immunological peptides for scientific or research use; nucleotides for scientific and research use
Services in the field of oncology and immunology, namely, medical analysis services for the diagnosis of cancer and immunological disorders; medical screening services in the fields of oncology and immunology.
Research and development in the fields of medicine in the nature of oncology and immunology; scientific research for medical purposes in the field of oncology; mining in the field of biology; biological research services; pharmaceutical research services; analysis of human tissues for medical research; drug discovery services; provision of information and data on oncology and immunology; biomedical research services conducted using databases; consultancy, information and advisory services in the fields of oncology and immunology
